Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Lymphoma 51Lymphoma, Follicular 36Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 29Lymphoma, Large B-Cell, Diffuse 25Lymphoma, Mantle-Cell 23Leukemia 23Lymphoma, Large-Cell, Immunoblastic 20Hodgkin Disease 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Leukemia, Myeloid, Acute 15Myelodysplastic Syndromes 12Multiple Myeloma 12Neoplasms, Plasma Cell 9Leukemia, Myeloid, Accelerated Phase 9Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Congenital Abnormalities 8Waldenstrom Macroglobulinemia 7Recurrence 7Blast Crisis 7Lymphoma, T-Cell, Cutaneous 6Primary Myelofibrosis 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Dendritic Cell Sarcoma, Interdigitating 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Flow Cytometry 3Methylprednisolone 2Immunologic Techniques 2Alemtuzumab 2sargramostim 1dexamethasone acetate 1dexamethasone 21-phosphate 1aldesleukin 1Tacrolimus 1Quality of Life 1Psychiatric Rehabilitation 1Prednisone 1Patient Reported Outcome Measures 1Moxifloxacin 1Molecular Diagnostic Techniques 1Microarray Analysis 1Interleukin-12 Subunit p35 1Interleukin-11 1Interferon-alpha 1Immunotherapy 1Immunoenzyme Techniques 1Granisetron 1Gene Expression Profiling 1Filgrastim 1ER 30346 1Drug Therapy 1Dexamethasone 1Data Collection 1Cyclophosphamide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gestational Trophoblastic Disease × sargramostim × Lymphoid × Clear all
NCT00003408 2013-03-26

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Teratoma, Testicular, Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Recurrence, Sarcoma, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡